ArticleDiscover oncology2025
Clinical characteristics, treatment status and prognosis analysis of elderly patients with ovarian cancer: a real world clinical study.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the clinical features, treatment status and identify the prognostic factors of elderly patients with ovarian cancer.
methodsIn this retrospective study, the clinical and survival data of 123 patients with ovarian cancer aged 65 years or older who were treated in Shaanxi Cancer Hospital from June 2019 to June 2023 were collected, and the clinical and prognostic factors were extracted and analyzed.
resultsAmong the 123 enrolled patients, 51.2% of the elderly patients with ovarian cancer received standard treatment, which includes surgery and chemotherapy with or without maintenance therapy, with no serious postoperative complications. Gene testing during treatment was just conducted in 30.9% of patients. The study found that surgery, standardized treatment, maintenance were linked to improved both PFS and OS, while age was only related to OS and > 71 years old was ignificantly associated with worse OS. Multivariate analysis revealed that both surgery (HR = 0.155, 95%CI 0.05-0.484, P = 0.001) and maintenance treatment (HR = 0.163, 95%CI 0.059-0.447, P < 0.001) are identified as independent prognostic factors for PFS, whereas surgery alone (HR = 0.289, 95%CI 0.107-0.78, P = 0.014) emerged as an independent prognostic factor for OS.
conclusionsOur real-world study demonstrates that just a small number of elderly patients with ovarian cancer received standard treatment and gene testing during treatment;those patients who accepted surgery, standardized treatment and maintenance had a better PFS and OS; the prognosis is even worse for patients who are older than 71;surgery and maintenance treatment are identified as independent prognostic factors for PFS, whereas surgery alone emerged as an independent prognostic factor for OS.While these findings provide valuable insights, it is important to note that this was a single-center retrospective analysis, and further validation in larger, prospective cohorts is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.